Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(10%)
Results Posted
50%(3 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
9
90%
Ph not_applicable
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

9

Late Stage

Phase Distribution10 total trials
Phase 4Post-market surveillance
9(90.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(6)
Terminated(2)
Other(1)

Detailed Status

Completed6
unknown1
Terminated1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 49 (90.0%)
N/A1 (10.0%)

Trials by Status

unknown110%
terminated110%
withdrawn110%
completed660%
recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10